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ORIGINAL ARTICLE
Translational medicine, which is a branch of med-
ical research that connects basic research more
directly to patient care, has received increasing
attention in the medical profession. In the case
of drug development, translational medicine typi-
cally refers to the translation of basic research
into real therapies for real patients. More specifi-
cally, Pizzo has defined translational medicine as
bench-to-bedside research, wherein a basic labo-
ratory discovery becomes applicable to the diag-
nosis, treatment or prevention of a specific disease,
and is brought forth by either a physician–scientist
who works at the interface between the research
laboratory and patient care, or by a team of basic
and clinical science investigators.1 Thus, transla-
tional medicine refers to the translation of basic
research discoveries into clinical applications.
In particular, translational medicine takes the
discoveries of basic research to patients and
measures endpoints in patients. Recently, scientists
have become increasingly aware that translational
research should be regarded as a two-way street,2
i.e. bench-to-bedside and bedside-to-bench. Basic
scientists provide clinicians with new tools for
use with patients and for assessment of their im-
pact, and clinical researchers make novel obser-
vations about the nature and progression of
disease that often stimulate basic investigations.
Mankoff et al pointed out that there are three
major obstacles to effective translational medicine
in practice, which are the challenge of translating
basic scientific discoveries into clinical studies, the
translation of clinical studies into medical prac-
tice and health care policy, and the misconception
that basic science will produce efficiently novel
therapies for human testing.3
Statistical processes play an important role in
translational medicine, and in particular: (1)
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identifying a functional relationship between
some independent parameters observed in basic
research discoveries and a dependent variable
observed from clinical application; (2) based on
the data observed in the study, conducting some
model-fitting analysis to establish a predictive
model between the independent parameters and
the dependent response variable; and (3) validat-
ing the established predictive model and assess-
ing whether the translational process is accurate
and reliable with statistical assurance. For example,
in drug development programs, the independent
variables may include in vitro assay results, phar-
macologic activities such as pharmacokinetics
and pharmacodynamics, and dose toxicities, and
the dependent variable could be a clinical out-
come (e.g. a safety parameter). Statistical meth-
ods related to (1) and (2) are well documented
in statistical literature. However, research effort is
needed to develop appropriate criteria to assess
the accuracy of a one-way and two-way transla-
tion process.
The purpose of this article is to introduce
basic statistical concepts and propose statistical
tests for one-way and two-way translation be-
tween basic research discoveries and clinical out-
come, under a well-established and validated
predictive model. In the next section on One-way
Translation, the concept of one-way translation 
is introduced. Also included in this section are
two proposed criteria and the corresponding 
statistical test for one-way translation. The Two-
way Translation section proposes a procedure 
for evaluation of two-way translation. Statistical 
assessment of the lost in translation is briefly 
discussed in the section Lost in Translation. This is
followed by some concluding remarks in the last
section.
One-way Translation
Let x and y be the observed values from basic re-
search discoveries and clinical application, respec-
tively. In practice, it is important to ensure that the
translational process is accurate and reliable, with
some statistical assurance. One of the statistical
criteria is to examine the closeness between the
observed response y and the predicted response
via a translational process. To study this, we will
first study the association between x and y and
build up a model, and then validate the model
based on some criteria. For simplicity, we assume
that x and y can be described by the following
linear model:
(1)
where e follows a normal distribution with mean
0 and variance .
Suppose that n pairs of observations (x1, y1),
…, (xn, yn) are observed in a translation process.
To define notation, let
and YT = (y1 y2 … yn). Then, under model (1),
the maximum likelihood estimates (MLE) of 
the parameters b0 and b1 are given as
with 
Thus, the following relationship
(2)
can be established between x and y, which are
the observed values from basic research discover-
ies and clinical application respectively.
Given xi, from (2), the corresponding fitted 
value is Furthermore, the corre-
sponding MLE of is 
, where MSE is the mean squared errors
of the fitted model.
For a given x = x0, suppose that the corre-
sponding observed value is given by y; using (2),
the corresponding fitted value is .
Note that and 
, where 
. Furthermore, is normally distrib-
uted with mean m0 and variance , i.e.
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Measures of closeness
We may validate the translation model by consid-
ering how close are an observed y and its predicted
value obtained based on the fitted regression
model given by (2). To assess the closeness, we
propose the following two measures, which are
based either on the absolute or the relative 
difference between y and :
Criterion I
Criterion II
In other words, we want a high probability that
the difference or the relative difference between y
and , given by p1 and p2 respectively, is less
than a clinically or scientifically meaningful dif-
ference d. Then, for either i = 1 or 2, it is of inter-
est to test the following hypotheses:
H0: pi≤ p0 vs. Ha: pi > p0 (3)
where p0 is some prespecified constant. If the
conclusion is to reject H0 in favor of Ha, this
would imply that the established model is con-
sidered validated. The steps in carrying out the
test of hypothesis corresponding to the two crite-
ria are outlined in the following section, and the
corresponding technical details in deriving the
test results are given in the Appendixes.
Measure of closeness based on absolute difference
It is easy to show that
where Φ is the cumulative density function of a
standard normal distribution. Thus, the MLE of
p1 is given by
Define
where f(z) is the probability density function of
a standard normal distribution. For a sufficiently
large sample size n, using Slutsky’s theorem,
can be approximated by a standard nor-
mal distribution.4 Details of the derivation can
be found in Appendix I. Based on these results,
for the testing of the hypotheses
H0: p1 ≤ p0 vs. Ha: p1 > p0,
H0 is rejected if , where z1–α is the
100(1–α)th percentile of a standard normal 
distribution.
Measure of closeness based on the absolute relative
difference
Consider the measure of closeness based on the
absolute relative difference 
Using results from Johnson and Kotz,5 it can be
shown that
,
where and Fu,u’ is a 
central F distribution with degrees of freedom 
and
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and are the corresponding MLE of
. For a sufficiently large sample size, 
can be approximated by a normal distribution
with mean p2 and variance V2, where the detailed
expression of V2 can be found in Appendix II.
Thus, the hypotheses given in (3) for one-way
translation based on the probability of relative
difference can be tested. In particular, H0 is 
rejected if
where z1−α is the 100(1−a)th percentile of a stan-
dard normal distribution. Note that is an esti-
mate of var and can be evaluated by simply
replacing the parameters with their correspon-
ding estimates of the parameters.
An example
For the two measures proposed in the above sec-
tion, p1 is based on the absolute difference between
y and . Given α, p0 and the selected observation
(x0, y0), the hypothesis H0: p1 ≤ p0 is rejected in 
favor of Ha: p1 > p0 when 
Equivalently, H0 is rejected when 
Note that the value of depends on
the value of d and it can be shown that 
is an increasing function of d
over (0, ∞). Details of the proof are given in
Appendix III. Thus, if and
only if d > d0. Thus, the hypothesis H0 can be re-
jected based on d0 instead of , as long as we can
find the value of d0 for the given x0. On the other
hand, from a practical point of view, p2 is easier
to understand because it is based on the relative
difference, which is equivalent to measuring the
percentage difference relative to the observed y,
and d can be viewed as the upper bound of the
percentage error.
For the purposes of illustration, suppose that
the following data are observed in a translational
study, where x is a given dose level and y is the 
associated toxicity measure:
When this set of data is fitted to model (1), the
estimates of the model parameters are given by
Thus, based
on the fitted results, given x = x0, the proposed
translation model is given by 
In this study, choose α = 0.05 and p0 = 0.8. In
particular, two dose levels x0 = 1.0 and 5.2 are
considered. Based on the study, the correspon-
ding toxicity measures y0 are 1.2 and 9.0, respec-
tively. However, based on the translation model,
the predicted toxicity measures are 1.147 and
8.921, respectively. In the following, the validity
of the translation model is assessed by the two
proposed closeness measures p1 and p2, respec-
tively. Without loss of generality, choose α = 0.05
and p0 = 0.8.
Case 1: Testing of H0: p1 ≤ p0 versus Ha: p1 > p0
Using the above results, for x0 = 1.0, d is 1.112,
since which is less
than d = 1.112. Therefore, H0 is rejected. Similarly,
for x0 = 5.2, the corresponding d is 1.178, then
which is again
smaller than d = 1.178. H0 is again rejected.
Case 2: Testing of H0: p2 ≤ p0 versus Ha: p2 > p0
Suppose that d = 1, for the two given values of x,
estimates of p2 and the corresponding values of
the test statistic Z are given in the following
table.
x0 y0 yˆ pˆ2 Z
1.0 1.2 1.147 0.870 1.183 Do not reject H0
5.2 9.0 8.921 0.809 1.164 Do not reject H0
0 ˆ 9.0 8.921 0.079,y y− = − =
0 ˆ 1.2 1.147 0.053,y y− = − =
01.851 .x
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Two-way Translation
Validation of a two-way translational process
The translational process described in the section
above is usually referred to as one-way transla-
tion in translational medicine. That is, the infor-
mation observed at basic research discoveries is
translated to the clinic. As indicated by Marincola,
the translational process should be a two-way
translation.1,2 In other words, we can exchange x
and y in (1):
(4)
and come up with another predictive model
.
Along similar lines, using either one of the
measures pi, the validation of a two-way trans-
lational process can be summarized by the 
following steps:
• Step 1: For a given set of data (x, y), establish a
predictive model, say, y = f(x).
• Step 2: Select the bound dyi for the difference
between y and . Evaluate .
Assess the one-way closeness between y and 
by testing the hypotheses (3). Proceed to the
next step if the one-way translation process is
validated.
• Step 3: Consider x as the dependent variable
and y as the independent variable. Set up the
regression model. Predict x at the selected ob-
servation y0, denoted by , based on the estab-
lished model between x and y (i.e. x = g(y)), 
i.e. 
• Step 4: Select the bound dxi for the difference
between x and . Evaluate the closeness be-
tween x and based on a test for the following
hypotheses
H0: pi≤ p0 vs. H1: pi > p0
where .
The above test can be referred to as a test for
two-way translation. If, in Step 4, H0 is rejected
in favor of H1, this would imply that there is a
two-way translation between x and y (i.e. the estab-
lished predictive model is validated). However,
the evaluation of p involved the joint distribu-
tion of and . An exact expression is
not readily available. Thus, an alternative ap-
proach is to modify Step 4 and proceed with a
conditional approach instead.
Step 4 (modified): Select the bound dxi for the
difference between x and . Evaluate the close-
ness between x and based on a test for the 
following hypotheses
H0: pxi ≤ p0 vs. Ha: pxi > p0 (5)
where .
Note that the evaluation of pxi is much easier
and can be computed in a similar way by inter-
changing the role of x and y for the results given
in Measures of closeness in the previous section
above.
An example (continued)
Using the data set given in An example in the pre-
vious section above, we set up the regression
model x = g0 + g1y + e, with y as the independent
variable and x as the dependent variable. The es-
timates of the model parameters are 
and Based on this
model, for the same a and p0, given that (x0,
y0) = (1.0, 1.2) and (5.2, 9.0), the fitted values
are given by .
Case 1: Testing of H0: px1 ≤ p0 versus Ha: px1 > p0
Using the above results, for y0 = 1.2, d is 0.587,
since which is less
than dx = 0.587. H0 is therefore rejected. Similarly,
for y0 =9.0, the corresponding d is 0.624, then
which is again
smaller than d = 0.624, thus H0 is rejected.
Case 2: Testing of H0: px2 ≤ p0 versus Ha: px2 > p0
Suppose that d=1, for the two given values of y,
estimates of px2 and the corresponding values of the
test statistic Z are given in the following table:
x0 y0 xˆ0 pˆx2 Z
1.0 1.2 1.090 0.809 1.300 Do not reject H0
5.2 9.0 5.139 0.845 16.53 Do not reject H0
0 ˆ 5.2 5.139 0.061,x x− = − =
0 ˆ 1.0 1.09 0.09,x x− = − =
0ˆ 0.468 0.519x y= +
2ˆ 0.121.=s
1ˆ 0.519,=g
0ˆ 0.468,=g
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Lost in Translation
It can be noted that dy and dx can be viewed as the
maximum bias (or possible lost in translation)
from the one-way translation (e.g. from basic re-
search discovery to the clinic) and from the other
way of translation (e.g. from the clinic to basic re-
search discovery), respectively. If dy and dx given
in steps 2 and 4 of Validation of a two-way transla-
tional process are close to 0, with a relatively high
probability, then we conclude that the informa-
tion from the basic research discoveries (the clinic)
is fully translated to the clinic (basic research dis-
coveries). Thus, one may consider the following
parameter to measure the degree of lost in trans-
lation: z = 1 – pxypyx, where pxy is the measure of
closeness from x to y, and pyx is the measure of
closeness from y to x. When z ≈ 0, we consider
that there is no lost in translation. Overall lost in
translation could be significant, even when lost
in translation from the one-way translation is
negligible. For illustrative purposes, if there is a
10% lost in translation in one-way translation
and 20% lost in translation the other way, there
would be up to 28% lost in translation. In prac-
tice, an estimate of z can be obtained for a given
set of data (x, y). In particular, 
As an illustration, consider the section An ex-
ample (continued) above. Suppose that the meas-
ure of closeness based on relative difference is
used, given (x0, y0) = (1.0, 1.2) and (5.2, 9.0), the
corresponding lost in translation for the two-way
translation with d = 1 is tabulated here:
Concluding Remarks
A commonly asked question in translational
medicine is whether results obtained based on an
animal model can be predictive, through a transla-
tional process, of a human model. This question
has to be addressed by testing for one-way and
two-way translation, and considering the similarity
between an animal and human model. In a more
general context, Chow et al proposed the idea of a
sensitivity index when changing from one popu-
lation to another, and explored how the effect size
under the human population is inflated (or re-
duced) by the sensitivity index.6 In particular, this
sensitivity index is a function of the shift in popu-
lation mean and/or in population standard devia-
tion from one population to the target population.
Chow et al derived statistical inference of the sen-
sitivity index for various patterns of the shifts in
population mean and population variance.7
In summary, translational medicine is a mul-
tidisciplinary entity that bridges basic scientific
research with clinical development. As the expense
in developing therapeutic pharmaceutical com-
pounds continues to increase and the success rates
for getting such compounds approved for market-
ing and to the patients needing these treatments
continues to decrease, a focused effort has emerged
in improving the communication and planning
between basic and clinical science. Translational
medicine contributes to the advancement of clini-
cal care through collaboration between scientists
and clinicians, which may lead to a substantial
increase in the number of safe and effective com-
pounds available to combat human diseases in a
more efficient way. However, in the process, statis-
tical methodology is an indispensable tool which
provides a scientific and systematic way to extract
useful information from the data collected in the
process of decision making. As demonstrated in
this study, the usefulness and validity of a trans-
lation process can be assessed by conducting 
relevant statistical inference based on some ap-
propriate closeness measures. The results in this
study help shed some insight into the use of 
different criteria, and certainly more research is
needed in this direction.
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Appendix I. Measure of Closeness Based on Absolute Difference
Note that y and are independent, thus ∼ N(0,(1 + c) ). It is easy to show that
. Thus, the MLE of p1 is given by
Using the delta rule, for sufficiently large sample size n,
var
where f(z) is the probability density function of a standard normal distribution. Furthermore, 
var can be estimated by V1, where V1 is given by
Using Slutsky’s theorem, can be approximated by a standard normal distribution.
Appendix II. Measure of Closeness Based on the Absolute Relative Difference
Note that and follow a non-central distribution with non-centrality parameter 
and , respectively, where m0 = b0 + b1x0. Hence, is doubly non-central F distributed with
u1 = 1 and u2 = 1 degrees of freedom and non-centrality parameters 
According to Johnson and Kotz,5 a non-central F distribution with u1 and u2 degrees of freedom can
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Thus, p2 can be estimated by
where , and are the corresponding MLE of
(l1, l2, u, u’).
For a sufficiently large sample size, using Slutsky’s theorem, can be approximated by a normal
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and (log Γ(s))(1) is the first 
order derivative of the natural logarithm of the gamma function with respect to s.
Appendix III
Prove: is an increasing function of d over (0, ∞) for large n.
Proof: Define . Note that and 
.
Therefore, , where
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Combining (A1) and (A2), we have
Note that Therefore, if and only if
The inequality holds if and only if
After some algebra, this is equivalent to
. Note that the right hand side is always less than 0 when n is large. Thus, u(d)
is an increasing function of d over (0, ∞) for large enough n.
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